Medical Care Technologies Inc.
MDCE · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2013 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.41 | 0.12 | 0.00 | 0.00 |
| FCF Yield | -10.06% | 0.46% | 1.55% | 0.00% |
| EV / EBITDA | 40.12 | 0.00 | 6.78 | -0.35 |
| Quality | ||||
| ROIC | 10.54% | -66.48% | 115.80% | 1,236.15% |
| Gross Margin | 49.03% | -7.82% | 38.34% | 0.00% |
| Cash Conversion Ratio | -4.10 | -0.08 | 0.13 | 0.09 |
| Growth | ||||
| Revenue 3-Year CAGR | -42.59% | – | – | – |
| Free Cash Flow Growth | -2,159.71% | -78.57% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.10 | 0.00 | 0.01 | -0.10 |
| Interest Coverage | 58.70 | -58.75 | 0.00 | -172.58 |
| Efficiency | ||||
| Inventory Turnover | 0.25 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 1,436.04 | 0.00 | -9.21 | 0.00 |